NCLAT: Corporate Debtor’s Guarantor Liability Unchanged Despite Internal Adjustments Among Creditors || NCLAT: Plea under IBC Section 7 Can't Be Restored After Corporate Debtor Pays Principal & Interest || Delhi HC: Wife Can Be Denied Maintenance If She Fails To Submit Latest Salary Slips || Kerala HC: Income of Parent Who Abandoned Family Shouldn’t Count For EWS Reservation Eligibility || Gujarat HC: Writ Courts Interfering in Arbitral Procedure Orders Defies A&C Act’s Purpose || Delhi HC: Plaintiff Doesn’t Have Vested Right to File Rejoinder under CPC || J&K&L HC: Name Change Is Fundamental Right; Boards Must Consider Legal Documents, Not Reject Request || SC: Administrative Delays by State Agencies Must Not Be Condoned || Sc: When Sale Deed Is Void, Possession Suit Follows 12-Year Limitation under Article 65, Not Art 59 || SC: Preliminary Inquiry Report Can’t Stop Court from Directing FIR Registration

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :